Skip to main content

Table 1 Characteristics of autopsy cases

From: Implication of overexpression of dishevelled-associated activator of morphogenesis 1 (Daam-1) for the pathogenesis of human Idiopathic Pulmonary Arterial Hypertension (IPAH)

A. PAH Cases

Patient

Diagnosis

H-E Grade

Age (years)

Sex

Underlying conditions

1a

APAH

II

4 months

Female

DORV and VSD

2a

APAH

II

5 months

Female

Trisomy 18 and VSD

3a

APAH

II

6 months

Female

DORV and VSD

4a

APAH

II

7 months

Female

Trisomy 21, ASD, and VSD

5

IPAH

III

13

Female

 

6

IPAH

IV

16

Female

 

7a

IPAH

IV

17

Female

 

8a

IPAH

IV

19

Female

 

9a

IPAH

III

21

Female

 

10

IPAH

IV

24

Male

 

11

APAH

VI

29

Male

Collagen disease

12

IPAH

IV

39

Female

 

13

APAH

IV

41

Male

Malignant lymphoma

14a

IPAH

III

44

Female

 

15a

IPAH

IV

51

Female

 

16a

APAH

III

63

Male

Collagen disease

B. Age-matched controls

Patient

Age (years)

Sex

Underlying conditions

  

17

3

Female

Pneumonia

  

18a

4

Male

Leukemia

  

19a

11

Female

Biliary atresia

  

20

14

Female

Leukemia

  

21a

14

Male

Leukemia

  

22a

15

Male

Leukemia

  

23a

16

Male

Hypertrophic cardiomyopathy

  

24

17

Male

Idiopathic myocarditis

  

25a

18

Male

Ewing sarcoma

  

26a

22

Female

Suicide

  

27a

23

Female

Cerebral hemorrhage

  

28a

29

Male

Chronic hepatitis

  

29

42

Male

Anterior mediastinal tumor

  

30

43

Female

Breast cancer

  

31a

47

Female

Gastric cancer

  

32a

56

Female

Subacute hepatitis

  

C. Summary

 

No.

Median age

Males:females

  

PAH cases

16

20 y (4 m - 63 y)

4:12

  

IPAH

9

21 y (13 y - 51 y)

1:8

  

APAH

7

7 m (4 m - 63 y)

3:4

  

Age-matched controls

16

18 y (3 y - 56 y)

8:8

  
  1. Cases are in ascending order of age
  2. H-E Grade, Heath–Edwards grade 36; DORV, double outlet right ventricle; VSD, ventricular septal defect; ASD, atrial septal defect
  3. a indicates that positive reactivity against both anti–Dvl-2 antibody and anti–Daam-1 antibody was confirmed in built-in control before further evaluation